| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 03/25/2003 | CA2301599C Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands |
| 03/20/2003 | WO2003022785A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 03/20/2003 | US20030055087 As analgesic |
| 03/20/2003 | US20030055073 Remedies for sjoegren's syndrome |
| 03/20/2003 | US20030055072 Methods of inhibiting Pin1-associated states using a fredericamycin a compound |
| 03/20/2003 | US20030055071 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV |
| 03/20/2003 | US20030055065 Administering tricyclic amide and urea compounds for inhibiting the abnormal growth of cells |
| 03/20/2003 | US20030054291 Multilayer; radiation transparent substrate, recording media, reflective layer and protective coatings |
| 03/20/2003 | CA2456614A1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 03/18/2003 | US6534522 Subtype-selective NMDA receptor ligands and the use thereof |
| 03/18/2003 | US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity |
| 03/18/2003 | US6534201 Organometallic luminescent materials and organic electroluminescent device containing same |
| 03/13/2003 | WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 03/13/2003 | US20030050475 Contacting a 5 or 6-methyl quinoxaline with a halogenating agent in the presence of radical initiator in solvent (mono,di,tri fluoro or chlorobenzenes or a,trichloro or fluorotoluene to form 5 or 6- halomethylquinoxaline |
| 03/13/2003 | US20030050319 Synthesis of intermediates useful in preparing tricyclic compounds |
| 03/13/2003 | CA2457534A1 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 03/12/2003 | EP1289999A1 Antitumoral analogs of et-743 |
| 03/12/2003 | EP1036058B1 Adamantane derivatives |
| 03/12/2003 | EP0789577B1 Synthesis of n-substituted oligomers |
| 03/11/2003 | US6531599 Compounds having activity as inhibitors of cytochrome P450RAI |
| 03/11/2003 | US6531481 Opiate compounds, methods of making and methods of use |
| 03/11/2003 | US6531464 Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives |
| 03/06/2003 | WO2003018537A1 Antiviral protease inhibitors |
| 03/06/2003 | US20030045545 Immunomodulators, induce cytokine biosynthesis, and antineoplastic agents |
| 03/06/2003 | CA2458040A1 Antiviral protease inhibitors |
| 03/05/2003 | EP1288203A1 Cyclic nitrones and pharmaceutical compositions containing them |
| 03/05/2003 | EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound |
| 03/05/2003 | EP1183255B1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 03/05/2003 | EP0882021B1 New phenanthridines |
| 03/05/2003 | EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof |
| 03/04/2003 | US6528534 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 03/04/2003 | US6528521 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 02/27/2003 | WO2003016281A1 A process of synthesis of a tricyclic ketone intermediate |
| 02/27/2003 | WO2003015715A2 Tetrahydroquinoline derivatives as antithrombotic agents |
| 02/27/2003 | WO2002086878A3 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers |
| 02/26/2003 | EP1284735A1 Apomorphine derivatives and methods for their use |
| 02/26/2003 | CN1399630A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 02/26/2003 | CN1398863A Benzo [b] pyran-[3,2-h] acridinyl-7-one compounds, their prepn and medicine composition containing them |
| 02/26/2003 | CN1102143C Process for producing (9 alpha, 13 alpha, 14 alpha)-1-(3-methoxy porphinan-17-group) alkylone |
| 02/25/2003 | US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine; |
| 02/20/2003 | WO2003013532A1 Chiral dinapsoline |
| 02/20/2003 | WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists |
| 02/20/2003 | CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 02/19/2003 | CN1397557A NOvel octahydro-2H-pyridino-[1,2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 02/19/2003 | CN1101812C Acorus calamus extracts in Acorus gramineus and their use |
| 02/19/2003 | CN1101811C Pictest-spengler reaction for synthesis of tetrahydroisoquinolines and related heterocyclic compounds |
| 02/18/2003 | US6521633 Treating NIDDM with RXR agonists |
| 02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | WO2002076988A3 Tert. alkylphenoxy substituted polycyclic compounds |
| 02/13/2003 | WO2002059082A8 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 02/13/2003 | CA2455179A1 Androgen receptor modulators and methods of use thereof |
| 02/12/2003 | EP1283202A1 Method for preparing heterocyclic-carboxylic acids |
| 02/12/2003 | EP1282732A1 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems |
| 02/12/2003 | EP0947514B1 Novel phenanethridinium derivatives |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/12/2003 | CN1101381C Method for extracting huperzine A as acetylcholinesterase depressant |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | CA2030715C Hexahydro-1h-quino¬4,3,2-ef|¬1,4|benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/05/2003 | EP1280809A1 Antitumoral ecteinascidin derivatives |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1280530A1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 02/05/2003 | EP0817632B1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1394860A 3-phenyl-3.7-diazobicyclo [3,3,1] nonane compound and its preparation method and medicine containing it |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/04/2003 | US6514990 Pharmaceutically active compounds and methods of use |
| 01/29/2003 | EP1161434B1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 01/29/2003 | CN1100056C Compound for inhibition of gastric acid secretion |
| 01/23/2003 | WO2002060436A3 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 01/23/2003 | US20030018199 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 01/23/2003 | US20030018041 Spiroindene and spiroindane compounds |
| 01/23/2003 | CA2417156A1 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient |
| 01/22/2003 | EP1277742A1 Method for preparing halomethyl heterocyclic compounds |
| 01/22/2003 | EP1277739A1 Method for preparing heterocyclic-carboxylic acids |
| 01/22/2003 | EP1276741A1 Phenyl substituted 4-hydroxy tetrahydropyridone |
| 01/22/2003 | EP0983247B1 Method for producing aromatic bisimides |
| 01/21/2003 | US6509356 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity |
| 01/21/2003 | US6509344 Indenoisoquinolines as antineoplastic agents |
| 01/21/2003 | US6509331 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/16/2003 | US20030013041 Write-once optical data carrier |
| 01/15/2003 | EP1275647A1 Octahydro-2H-pyrido[1,2-a]pyrazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1274688A1 Synthesis of intermediates useful in preparing tricyclic compounds |
| 01/15/2003 | EP1274411A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 01/15/2003 | EP1274408A2 Use of natural chrysanthone compounds having antiangiogenic activity |
| 01/14/2003 | US6506765 Apomorphine derivatives and methods for their use |
| 01/14/2003 | US6506764 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | CA2217477C Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 01/09/2003 | WO2002080152A3 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer |
| 01/09/2003 | US20030008890 For therapy of neurological and psychological disorders |
| 01/09/2003 | US20030008234 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 01/09/2003 | US20030006516 Radiation transparent subsrates; reflecting layer |
| 01/08/2003 | EP1272471A1 Non-steroidal, tetracyclic compounds for estrogen-related treatments |
| 01/08/2003 | EP0863878B1 Cyclic nitrones and pharmaceutical compositions containing them |
| 01/08/2003 | CN1390122A Tissue factor antagonists and methods of use thereof |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000661A1 Metal coordination compound and electroluminescence device |
| 01/03/2003 | WO2003000261A1 Use of bicyclo compounds for treating alzheimer's disease |
| 01/03/2003 | CA2451664A1 Use of bicyclo compounds for treating alzheimer's disease |
| 01/02/2003 | US20030004344 Thrombin or factor Xa inhibitors |